176 related articles for article (PubMed ID: 34492737)
1. Diffuse large B-cell lymphoma genetics - simplifying the subtyping.
Hodson DJ
Br J Haematol; 2021 Dec; 195(5):651-652. PubMed ID: 34492737
[No Abstract] [Full Text] [Related]
2. Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.
Gifford GK; Gill AJ; Stevenson WS
Pathology; 2016 Jan; 48(1):5-16. PubMed ID: 27020203
[TBL] [Abstract][Full Text] [Related]
3. Burkitt lymphoma and diffuse aggressive B-cell lymphoma.
Forteza-Vila J; Fraga M
Int J Surg Pathol; 2010 Jun; 18(3 Suppl):133S-135S. PubMed ID: 20484278
[No Abstract] [Full Text] [Related]
4. [Molecular subtyping of diffuse large B-cell lymphoma].
Li XQ
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):993-995. PubMed ID: 32992410
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum.
Momose S; Weißbach S; Pischimarov J; Nedeva T; Bach E; Rudelius M; Geissinger E; Staiger AM; Ott G; Rosenwald A
Leukemia; 2015 Aug; 29(8):1789-91. PubMed ID: 25673238
[No Abstract] [Full Text] [Related]
6. [Molecular classification of aggressive B-cell lymphoma].
Ennishi D
Rinsho Ketsueki; 2021; 62(5):418-423. PubMed ID: 34108323
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood and bone marrow findings in B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Ahmad OS; Fishlock K; May P; Kanfer E; Naresh KN
Am J Hematol; 2012 Feb; 87(2):201-2. PubMed ID: 22139902
[No Abstract] [Full Text] [Related]
8. Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.
Suzuki M; Muroi A; Nojima M; Numata A; Takasaki H; Sakai R; Yokose T; Miyagi Y; Koshikawa N
Proteomics Clin Appl; 2020 Jan; 14(1):e1900091. PubMed ID: 31721454
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphological clues for a correct diagnosis of anaplastic lymphoma kinase-positive large B-cell lymphoma.
Guleria P; Mallick SR; Ramteke P; Jain D
Cytopathology; 2019 Jul; 30(4):432-435. PubMed ID: 30007099
[No Abstract] [Full Text] [Related]
10. Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma.
Nowakowski GS; Vitolo U
Future Oncol; 2017 Apr; 13(10):859-862. PubMed ID: 28183193
[No Abstract] [Full Text] [Related]
11. Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status.
Kendrick S; Tus K; Wright G; Jaffe ES; Rosenwald A; Campo E; Chan WC; Connors JM; Braziel RM; Ott G; Delabie J; Cook JR; Weisenburger DD; Greiner TC; Fu K; Staudt LM; Gascoyne RD; Scott DW; Rimsza LM
Leuk Lymphoma; 2016; 57(3):717-20. PubMed ID: 26437080
[No Abstract] [Full Text] [Related]
12. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
Hiraga J; Katsumi A; Iwasaki T; Abe A; Kiyoi H; Matsushita T; Kinoshita T; Naoe T
Leukemia; 2007 Aug; 21(8):1846-7. PubMed ID: 17443219
[No Abstract] [Full Text] [Related]
13. The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.
Dunleavy K; Staudt LM; Wilson WH
Leuk Lymphoma; 2007 Jun; 48(6):1061-3. PubMed ID: 17577765
[No Abstract] [Full Text] [Related]
14. B-cell lymphoma in a tubular adenoma with high-grade dysplasia: a rare extramedullary manifestation of high-grade diffuse large B-cell lymphoma.
Roeb E; Rummel M; Blau W; Etschmann B; Gattenlöhner S
Endoscopy; 2011; 43 Suppl 2 UCTN():E344-5. PubMed ID: 22020719
[No Abstract] [Full Text] [Related]
15. MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Troppan K; Wenzl K; Deutsch A; Ling H; Neumeister P; Pichler M
Anticancer Res; 2014 Feb; 34(2):557-64. PubMed ID: 24510984
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma.
Abubaker J; Bavi PP; Al-Harbi S; Siraj AK; Al-Dayel F; Uddin S; Al-Kuraya K
Leukemia; 2007 Nov; 21(11):2368-70. PubMed ID: 17657213
[No Abstract] [Full Text] [Related]
17. A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse large B-cell lymphoma with immature features or B-cell lymphoblastic lymphoma?
Ronchi A; Zito Marino F; Vitiello P; Caccavale S; Argenziano G; Crisci S; Franco R; Sica A
J Cutan Pathol; 2021 Apr; 48(4):535-540. PubMed ID: 32623764
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA assessment in patients with diffuse large B-cell lymphoma following CAR T-cell therapy.
Hossain NM; Dahiya S; Le R; Abramian AM; Kong KA; Muffly LS; Miklos DB
Leuk Lymphoma; 2019 Feb; 60(2):503-506. PubMed ID: 29966461
[No Abstract] [Full Text] [Related]
19. Genetics of Diffuse Large B-Cell Lymphoma.
Wright GW; Wilson WH; Staudt LM
N Engl J Med; 2018 Aug; 379(5):493-494. PubMed ID: 30067933
[No Abstract] [Full Text] [Related]
20. High prevalence of
Schrader AMR; Jansen PM; Willemze R; Vermeer MH; Cleton-Jansen AM; Somers SF; Veelken H; van Eijk R; Kraan W; Kersten MJ; van den Brand M; Stevens WBC; de Jong D; Abdul Hamid M; Tanis BC; Posthuma EFM; Nijland M; Diepstra A; Pals ST; Cleven AHG; Vermaat JSP
Blood; 2018 May; 131(18):2086-2089. PubMed ID: 29514783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
